Article
- The EMBO Journal (2007) 26, 647 - 656
- doi:10.1038/sj.emboj.7601534
Published online: 25 January 2007
Subject Category:
CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery
Jin-Min Nam1,2, Yasuhito Onodera1,2, Yuichi Mazaki1, Hiroyuki Miyoshi3, Shigeru Hashimoto1 and Hisataka Sabe1,2
- Department of Molecular Biology, Osaka Bioscience Institute, Suita, Osaka, Japan
- Graduate School of Biostudies, Kyoto University, Kyoto, Japan
- Subteam for Manipulation of Cell Fate, BioResource Center, RIKEN Tsukuba Institute, Tsukuba, Japan
Correspondence to:
Hisataka Sabe, Department of Molecular Biology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565-0874, Japan. Tel.: +81 6 6872 4814; Fax: +81 6 6871 6686; E-mail: sabe@obi.or.jp
Received 30 August 2006; Accepted 7 December 2006
Abstract
Expression of AMAP1 correlates well with the invasive phenotypes and malignancy of human primary breast carcinomas. AMAP1 recruits its binding proteins, such as cortactin and paxillin, to sites of Arf6 activation to form invadopodia. A mouse ortholog of AMAP1, ASAP1, is known to bind to CIN85, a binding partner of an E3 ligase, Cbl. Here, we found that CIN85 colocalizes with AMAP1 at invadopodia, and binding of AMAP1 with CIN85 is important for the invasive activities of breast cancer cells, including MDA-MB-231. siRNA-mediated silencing of CIN85, as well as Cbl, also inhibited the invasion. We moreover found that AMAP1 is monoubiquitinated, rather than polyubiquitinated, by virtue of Cbl and provide evidence that the ability of AMAP1 to be monoubiquitinated is important for its involvement in invasion. Our results indicate that CIN85, as well as Cbl, which is a well-known suppressor of growth factor receptor signaling, can be positively involved in tumor invasion, and suggest that a complex epigenetic process is involved in AMAP1 function in breast cancer cell invasion.
Keywords:
- AMAP1,
- breast cancer,
- invasion,
- ubiquitination
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Oncogene Review
NEWS AND VIEWS
Signal transduction Molecular ticket to enter cells
Nature News and Views (14 Feb 2002)
RESEARCH
Oncogene Original Article
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Nature Letters to Editor (14 Apr 2005)
Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities
The EMBO Journal Article (09 Mar 2005)



